Additionally, miR-130a was found to alleviate human coronary artery endothelial cell injury, inflammatory responses, cardiac dysfunction, and myocardial infarction by down-regulating PTEN and activating the PI3K/Akt/eNOS signaling pathway [24,25]. This evidence concerns the gene AKT1 and myocardial infarction.